InvestorsHub Logo
Followers 150
Posts 15039
Boards Moderated 1
Alias Born 07/07/2002

Re: None

Tuesday, 10/21/2003 4:14:03 PM

Tuesday, October 21, 2003 4:14:03 PM

Post# of 275590
LSBC should have a gap in morning on news - Tuesday October 21, 4:00 pm ET

VACAVILLE, Calif.--(BUSINESS WIRE)--Oct. 21, 2003--Large Scale Biology Corporation (Nasdaq: LSBC - News) today announced the inclusion of funding in the Fiscal Year 2004 Department of Defense (DOD) Appropriations bill for its Genetic Reassortment by Mismatched Repair-Enhanced Acute Biowarfare Therapy Program. The funding will be used to initiate a collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland. The research and development program will apply LSBC's proprietary GRAMMR(TM) (Genetic ReAssortment by MisMatch Resolution) DNA shuffling and molecular evolution technologies to render particular therapeutic candidate products more effective for biowarfare therapy and prophylaxis.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.